Detalhe da pesquisa
1.
Active-site mTOR inhibitors augment HSV1-dICP0 infection in cancer cells via dysregulated eIF4E/4E-BP axis.
PLoS Pathog
; 14(8): e1007264, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30138450
2.
Genetic modification of oncolytic viruses to enhance antitumor immunity.
Methods Enzymol
; 635: 231-250, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32122548
3.
Oncolytic viruses: how "lytic" must they be for therapeutic efficacy?
Oncoimmunology
; 8(6): e1581528, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31069150
4.
Pre-surgical neoadjuvant oncolytic virotherapy confers protection against rechallenge in a murine model of breast cancer.
Sci Rep
; 9(1): 1865, 2019 02 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30755678